FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137332012> ?p ?o ?g. }

• W2137332012 endingPage "179" @default.
• W2137332012 startingPage "166" @default.
• W2137332012 abstract "The front-line management of stage IV indolent non-Hodgkin's lymphoma has ranged from the watch-and-wait approach to intensive experimental regimens such as high-dose chemotherapy and bone marrow transplant. With this broad spectrum of regimens to choose from the decision has become a challenging exercise for both patients and oncologists. With the recent introduction of new agents such as rituximab, fludarabine, and combinations based on these, the management of relapsed cases can be similarly confusing. More aggressive approaches such as high-dose chemotherapy with autologous bone marrow transplant and more recently allogeneic bone marrow transplant have also been used. Recently the technique of mini-allo transplants has been introduced. It utilizes a less myelosuppressive conditioning chemotherapy regimen based on fludarabine which is immunosuppressive enough to allow engraftment of the donor marrow. Since it is less myelotoxic it is better tolerated, and this has allowed us to significantly extend the age cut-off for allogeneic transplants. All these advances provide us with a more extensive armamentarium, but at the same time they confront physicians with new challenges in choosing from a large and continuously growing therapeutic menu. In this review of the alternative therapies a panel of three expert hemato-oncologists each discuss their approach to the management of a 49-year-old patient with a relapsed indolent follicular lymphoma. Dr. Horning discusses the traditional alternatives available for this patient such as standard chemotherapy combinations or the watch-and-wait approach in Section I. In Section II, Dr. Kaminski reviews the different therapeutic monoclonal antibody options such as rituximab, Bexxar (Iodine-labeled anti-CD20) and Ytrium-labeled anti-CD20 antibody. Allogeneic transplants are increasingly more popular for the treatment of indolent lymphomas because they can provide an immune-mediated graft-versus-lymphoma effect. In Section III, Dr. Richard Champlin reviews various transplant options including autologous, allogeneic and mini-allogeneic transplants." @default.
• W2137332012 created "2016-06-24" @default.
• W2137332012 creator A5003239953 @default.
• W2137332012 date "2000-01-01" @default.
• W2137332012 modified "2023-10-17" @default.
• W2137332012 title "Managing Indolent Lymphomas in Relapse: Working Our Way Through a Plethora of Options" @default.
• W2137332012 cites W122133057 @default.
• W2137332012 cites W1494274243 @default.
• W2137332012 cites W1504115866 @default.
• W2137332012 cites W1512178367 @default.
• W2137332012 cites W1519928058 @default.
• W2137332012 cites W1520514406 @default.
• W2137332012 cites W1545991364 @default.
• W2137332012 cites W1550827013 @default.
• W2137332012 cites W1573890015 @default.
• W2137332012 cites W1606620269 @default.
• W2137332012 cites W161006781 @default.
• W2137332012 cites W177504901 @default.
• W2137332012 cites W1777323899 @default.
• W2137332012 cites W1785340630 @default.
• W2137332012 cites W1794039173 @default.
• W2137332012 cites W1794119559 @default.
• W2137332012 cites W1848698181 @default.
• W2137332012 cites W1849027585 @default.
• W2137332012 cites W1849688341 @default.
• W2137332012 cites W18663925 @default.
• W2137332012 cites W1868627100 @default.
• W2137332012 cites W1874821077 @default.
• W2137332012 cites W1877303819 @default.
• W2137332012 cites W1883328448 @default.
• W2137332012 cites W1885678484 @default.
• W2137332012 cites W1915689252 @default.
• W2137332012 cites W1921096083 @default.
• W2137332012 cites W1921508210 @default.
• W2137332012 cites W1931321618 @default.
• W2137332012 cites W1937538988 @default.
• W2137332012 cites W1945274657 @default.
• W2137332012 cites W1969275068 @default.
• W2137332012 cites W1987759419 @default.
• W2137332012 cites W1995981131 @default.
• W2137332012 cites W2033228381 @default.
• W2137332012 cites W2042100003 @default.
• W2137332012 cites W2065738009 @default.
• W2137332012 cites W2069567277 @default.
• W2137332012 cites W2098698745 @default.
• W2137332012 cites W2112041130 @default.
• W2137332012 cites W2135157531 @default.
• W2137332012 cites W2136326451 @default.
• W2137332012 cites W2146435543 @default.
• W2137332012 cites W2164879008 @default.
• W2137332012 cites W2168926834 @default.
• W2137332012 cites W2178425449 @default.
• W2137332012 cites W2206250717 @default.
• W2137332012 cites W2207262939 @default.
• W2137332012 cites W2229863299 @default.
• W2137332012 cites W2255034921 @default.
• W2137332012 cites W2256392563 @default.
• W2137332012 cites W2266889995 @default.
• W2137332012 cites W2267408946 @default.
• W2137332012 cites W2314699739 @default.
• W2137332012 cites W2324339443 @default.
• W2137332012 cites W2327610290 @default.
• W2137332012 cites W2338573834 @default.
• W2137332012 cites W2395585278 @default.
• W2137332012 cites W2413552836 @default.
• W2137332012 cites W2415603966 @default.
• W2137332012 cites W2588779176 @default.
• W2137332012 cites W2946187815 @default.
• W2137332012 cites W40839337 @default.
• W2137332012 cites W64930248 @default.
• W2137332012 cites W76972160 @default.
• W2137332012 cites W93168681 @default.
• W2137332012 cites W2406472840 @default.
• W2137332012 doi "https://doi.org/10.1182/asheducation-2000.1.166" @default.
• W2137332012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11701541" @default.
• W2137332012 hasPublicationYear "2000" @default.
• W2137332012 type Work @default.
• W2137332012 sameAs 2137332012 @default.
• W2137332012 citedByCount "12" @default.
• W2137332012 countsByYear W21373320122014 @default.
• W2137332012 crossrefType "journal-article" @default.
• W2137332012 hasAuthorship W2137332012A5003239953 @default.
• W2137332012 hasConcept C126322002 @default.
• W2137332012 hasConcept C143998085 @default.
• W2137332012 hasConcept C177713679 @default.
• W2137332012 hasConcept C2776694085 @default.
• W2137332012 hasConcept C2776755627 @default.
• W2137332012 hasConcept C2777058707 @default.
• W2137332012 hasConcept C2779263901 @default.
• W2137332012 hasConcept C2779338263 @default.
• W2137332012 hasConcept C2780007613 @default.
• W2137332012 hasConcept C2780653079 @default.
• W2137332012 hasConcept C71924100 @default.
• W2137332012 hasConceptScore W2137332012C126322002 @default.
• W2137332012 hasConceptScore W2137332012C143998085 @default.
• W2137332012 hasConceptScore W2137332012C177713679 @default.
• W2137332012 hasConceptScore W2137332012C2776694085 @default.
• W2137332012 hasConceptScore W2137332012C2776755627 @default.

• next